Sort
78,016 grants matching “breast cancer”
A GIS Based Workbench to Interpret Cancer Maps
$440,717University Of Iowa · R01 · FY2004 · CA
Deciphering the Code for Senescence Escape During Cancer Progression in Humans
$440,674Utz Herbig · Rbhs-New Jersey Medical School · R01 · FY2018 · CA
Leadership, Administration and Statisitical Analysis
$440,662Susan E. Hankinson · Brigham And Women'S Hospital · P01 · FY2011 · CA
PET-MRI for Assessing Treatment Response in Breast Cancer Clinical Trials
$440,658Thomas E Yankeelov · Vanderbilt University · U01 · FY2011 · CA
Socioeconomic Trends in Breast Cancer Incidence
$440,648Harvard University (Sch Of Public Hlth) · R01 · FY2005 · CA
Mechanisms governing metastatic reactivation of breast cancer.
$440,646Filippo G Giancotti · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA
Mechanisms governing metastatic reactivation of breast cancer.
$440,646Filippo G Giancotti · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA
Meiotic Interactions of the RecA Homologue Dmc1
$440,606Douglas K. Bishop · University Of Chicago · R01 · FY2009 · GM
The molecular mechanisms of progestin efficacy and resistance in EC-AEH
$440,602Miles A Pufall · University Of New Mexico Health Scis Ctr · P01 · FY2025 · CA
Unravelling the mechanism of acai BDS-anticancer drug interaction: A preliminary approach
$440,590Angela Isabel Calderon · Auburn University At Auburn · R15 · FY2021 · AT
A PERSONALIZED THERAPEUTIC VACCINE FOR PREVENTION OF METASTATIC OUTGROWTH OF BREAST CANCER
$440,586Oklahoma Medical Research Foundation · · FY2012 · Department of Defense
Transport of Effector T cells and Nano-DC vaccine in Breast Cancer
$440,580Rongfu Wang · Methodist Hospital Research Institute · U54 · FY2019 · CA
Experimental Integration, Design and Analysis Core
$440,562Janet L Stein · University Of Vermont & St Agric College · P01 · FY2023 · CA
Multiscale anisotropy analysis of breast tissue subtypes from mammography and pathology
$440,561Andre Khalil · University Of Maine Orono · R15 · FY2025 · CA
An integrated polymeric carrier for subunit cancer vaccines
$440,520Suzie H Pun · University Of Washington · R01 · FY2022 · CA
Noncanonical signaling and Emergent Trastuzumab Resistance in Breast Cancer
$440,510David John Klinke · West Virginia University · R15 · FY2012 · CA
ST Louis-Cape Girardeau CCOP
$440,482Bethany Sleckman · St. John'S Mercy Medical Center · U10 · FY2007 · CA
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer
$440,432David Danforth · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA
RNAi Analysis and Screening for Study of Genes and Anti-Cancer Treatments
$440,382Natasha Caplen · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
the mTOR translational control pathway in tamoxifen resistant ER+ breast cancer
$440,359Robert Schneider · New York University School Of Medicine · R01 · FY2021 · CA
Multiscale hydrogel biomaterials-enabled 3D modeling of cancer drug resistance
$440,347Xiaoming He · Univ Of Maryland, College Park · R01 · FY2023 · CA
Development of assays for HTS to identify inhibitors of a new PPI involved in cancer metastasis
$440,344Celine Dermardirossian · Scripps Research Institute, The · R01 · FY2017 · CA
Regulation of Hsp70-Mediated Cyclin D1 Destruction in Breast Cancer
$440,338Andrew William Truman · University Of North Carolina Charlotte · R15 · FY2017 · CA
SOUTHWEST ONCOLOGY GROUP CA-13612
$440,336University Of Arizona · U10 · FY2002 · CA
TARGETING ALPHA5 BETA1 INTEGRIN TO PREVENT METASTATIC BREAST CANCER CELL INVASION: PHSCN TARGET SITE DEFINITION AND PLASMA STABILITY
$440,310Regents Of The University Of Michigan · · FY2012 · Department of Defense